共 156 条
[1]
Ost P(2018)Surveillance or metastasis-directed therapy for Oligometastatic prostate Cancer recurrence: a prospective, randomized, multicenter phase II trial J Clin Oncol 36 446-453
[2]
Reynders D(2018)Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial Eur Urol 74 455-462
[3]
Decaestecker K(2017)A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE) BMC Cancer 17 453-863
[4]
Fonteyne V(2015)Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature Eur Urol 67 852-1151
[5]
Lumen N(2001)Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165 1146-1410
[6]
De Bruycker A(2012)High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 82 1405-1597
[7]
Siva S(1999)Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1591-247
[8]
Bressel M(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) EJC 45 228-1418
[9]
Murphy DG(2016)Trial design and objectives for castration-resistant prostate Cancer: updated recommendations from the prostate Cancer clinical trials working group 3 J Clin Oncol 34 1402-897
[10]
Shaw M(2012)Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer Int J Radiat Oncol Biol Phys 82 889-270